# The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)

Study · id `cardio:ct-nct03120299` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03120299](<https://clinicaltrials.gov/study/NCT03120299>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03120299

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 309 participants.

## Technical summary

Registry record NCT03120299. Randomized; quadruple masking; primary purpose treatment. Start 2017-05-01 (actual); primary completion 2021-03-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 309 participants (enrolled count; ClinicalTrials.gov record NCT03120299, source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)
- Started: 2017-05-01 (actual) (ClinicalTrials.gov record NCT03120299, source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)
- Primary completion: 2021-03-01 (actual) (ClinicalTrials.gov record NCT03120299, source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)
- Completion: 2021-06-01 (actual) (ClinicalTrials.gov record NCT03120299, source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03120299, source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03120299-2023-10-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
- Condition: Type 2 Diabetes Mellitus
- Condition: Hypertriglyceridemia
- Intervention (Drug): Omega-3 fatty acid
- Intervention (Drug): Placebos
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes (`cardio:pubmed-39163858`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8c1b04f09b2591f5ee9d93fd4a2723bf89e0d68720e03dee0baeb36e38f9475a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
